| 1. What is your primary specialty? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Hematology |  | 12.5% | 4 |
| Oncology | | 56.3% | 18 |
| Hematology-Oncology | | 31.3% | 10 |
 Other (please specify) | 3 | ||
| answered question | 32 | ||
| skipped question | 2 | ||
| 2. How many years have you been in practice? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| 1-5 | | 5.9% | 2 |
| 6-10 | | 23.5% | 8 |
| 11-20 | | 35.3% | 12 |
| 21-30 | | 29.4% | 10 |
| 31 or more | | 5.9% | 2 |
| answered question | 34 | ||
| skipped question | 0 | ||
| 3. Which is your preferred ESA drug for treating anemia? Please pick only one. | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Aranesp | | 45.2% | 14 |
| Epogen | | 25.8% | 8 |
| Procrit | | 29.0% | 9 |
| Other (please specify) | 3 | ||
| answered question | 31 | ||
| skipped question | 3 | ||
| 4. Do you believe that these drugs are similar and interchangeable in most patients? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 76.5% | 26 |
| No | | 11.8% | 4 |
| Depends on the specific patient. | | 11.8% | 4 |
| Other (please specify) | 0 | ||
| answered question | 34 | ||
| skipped question | 0 | ||
| 5. Medicare is proposing that it will restrict payments for these drugs for certain conditions only, for specific hemoglobin levels only, and will not pay for prophylactic use. Do you agree with this Medicare ruling? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 52.9% | 18 |
| No | | 47.1% | 16 |
| Other (please specify) | 0 | ||
| answered question | 34 | ||
| skipped question | 0 | ||
| 6. Some private health insurance companies have also taken Medicare's lead and are restricting payments for these drugs. Do you agree with this policy? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 45.5% | 15 |
| No | | 54.5% | 18 |
| Other (please specify) | 0 | ||
| answered question | 33 | ||
| skipped question | 1 | ||
| 7. From your experience, do you feel that these prescribing restrictions will have an adverse effect on your patients who need these drugs to stay healthy? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 50.0% | 16 |
| No | | 50.0% | 16 |
| Other (please specify) | 1 | ||
| answered question | 32 | ||
| skipped question | 2 | ||
| 8. Have you had any patients who developed medical complications as a result of reduced access to these drugs because of the expense of the drugs? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 42.4% | 14 |
| No | | 57.6% | 19 |
| Other (please specify) | 1 | ||
| answered question | 33 | ||
| skipped question | 1 | ||
| 9. In November 2007 the FDA changed the labeling on ESAs after several studies showed that certain dosages of some of these drugs were associated with more rapid growth of certain cancers and reduced survival rates. Do you agree with the conclusions of these studies? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 65.6% | 21 |
| No | | 34.4% | 11 |
| Other (please specify) | 2 | ||
| answered question | 32 | ||
| skipped question | 2 | ||
| 10. As a result of the studies revealed by the drug manufacturers and FDA in Novemeber 2007, how have you changed your prescribing of ESAs? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| I have not changed my prescribing practices. | | 33.3% | 11 |
| I have reduced the dosages prescribed but have not reduced the number of patients I am prescribing these drugs to. | | 15.2% | 5 |
| I have reduced the number of patients I am prescribing these drugs to. | | 39.4% | 13 |
| I am reducing the dosage prescribed only in patients with certain types of cancers. | | 12.1% | 4 |
| I am eliminating prescribing these drugs in patients with certain types of cancers. | | 3.0% | 1 |
| Other (please specify) | 1 | ||
| answered question | 33 | ||
| skipped question | 1 | ||
| 11. Have any of your patients who are on ESAs asked you about the recent bad publicity of ESA drugs? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 47.1% | 16 |
| No | | 52.9% | 18 |
| Other (please specify) | 0 | ||
| answered question | 34 | ||
| skipped question | 0 | ||
| 12. Have any of your patients who are on ESAs asked to stop these drugs as a result of the bad publicity? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 5.9% | 2 |
| No | | 94.1% | 32 |
| Other (please specify) | 0 | ||
| answered question | 34 | ||
| skipped question | 0 | ||
| 13. Have you had to prescribe more blood transfusions as a result of the FDA ESA advisories in Novemeber 2007, and the recent Medicare and private insurance restrictions for ESAs? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 35.3% | 12 |
| No | | 64.7% | 22 |
| Other (please specify) | 0 | ||
| answered question | 34 | ||
| skipped question | 0 | ||
| 14. Do you like to participate in online healthcare surveys? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 93.8% | 30 |
| No | | 6.3% | 2 |
| Other (please specify) | 2 | ||
| answered question | 32 | ||
| skipped question | 2 | ||
| 15. Would you like to participate in additional WhatDoctorsThink.com online surveys? You can see some other public surveys we've performed at http://whatdoctorsthink.com/surveysamples.html | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 90.9% | 30 |
| No | | 12.1% | 4 |
| Other (please specify) | 2 | ||
| answered question | 33 | ||
| skipped question | 1 | ||
| 16. Would you like to participate in various other types of online surveys where you receive honorariums for your time and expertise? | |||
|---|---|---|---|
| Response Percent | Response Count | ||
| Yes | | 93.5% | 29 |
| No | | 6.5% | 2 |
| Other (please specify) | 2 | ||
| answered question | 31 | ||
| skipped question | 3 | ||